Unio Capital LLC Purchases 1,238 Shares of UnitedHealth Group Inc (UNH)

Unio Capital LLC raised its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 6.1% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 21,514 shares of the healthcare conglomerate’s stock after purchasing an additional 1,238 shares during the period. UnitedHealth Group comprises 3.8% of Unio Capital LLC’s portfolio, making the stock its 10th biggest position. Unio Capital LLC’s holdings in UnitedHealth Group were worth $4,604,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of UNH. Egerton Capital UK LLP purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at $368,905,000. Amundi Pioneer Asset Management Inc. increased its holdings in shares of UnitedHealth Group by 72.1% in the 4th quarter. Amundi Pioneer Asset Management Inc. now owns 1,919,846 shares of the healthcare conglomerate’s stock valued at $423,249,000 after acquiring an additional 804,091 shares during the period. Arrowstreet Capital Limited Partnership increased its holdings in shares of UnitedHealth Group by 22.4% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 4,323,180 shares of the healthcare conglomerate’s stock valued at $953,088,000 after acquiring an additional 792,527 shares during the period. Westfield Capital Management Co. LP purchased a new position in shares of UnitedHealth Group in the 1st quarter valued at $152,388,000. Finally, OppenheimerFunds Inc. increased its holdings in shares of UnitedHealth Group by 19.5% in the 1st quarter. OppenheimerFunds Inc. now owns 3,731,116 shares of the healthcare conglomerate’s stock valued at $798,458,000 after acquiring an additional 609,058 shares during the period. 84.94% of the stock is owned by institutional investors and hedge funds.

Several research analysts recently weighed in on UNH shares. Barclays started coverage on UnitedHealth Group in a research note on Thursday, March 8th. They set an “overweight” rating and a $265.00 target price on the stock. Cantor Fitzgerald restated a “buy” rating and set a $280.00 target price on shares of UnitedHealth Group in a research note on Thursday, March 8th. Credit Suisse Group restated a “buy” rating on shares of UnitedHealth Group in a research note on Friday, March 9th. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, March 20th. Finally, JPMorgan Chase & Co. boosted their target price on UnitedHealth Group to $266.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 18th. One investment analyst has rated the stock with a hold rating and twenty-six have assigned a buy rating to the company. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $263.00.

UnitedHealth Group opened at $244.90 on Friday, Marketbeat Ratings reports. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.56. The stock has a market cap of $240.02 billion, a price-to-earnings ratio of 24.32, a PEG ratio of 1.44 and a beta of 0.74. UnitedHealth Group Inc has a fifty-two week low of $183.86 and a fifty-two week high of $256.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 17th. The healthcare conglomerate reported $3.04 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.91 by $0.13. The business had revenue of $55.19 billion for the quarter, compared to the consensus estimate of $54.90 billion. UnitedHealth Group had a return on equity of 22.06% and a net margin of 5.41%. The company’s quarterly revenue was up 13.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.37 EPS. research analysts forecast that UnitedHealth Group Inc will post 12.62 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 26th. Stockholders of record on Monday, June 18th were issued a $0.90 dividend. This represents a $3.60 annualized dividend and a dividend yield of 1.47%. The ex-dividend date was Friday, June 15th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $0.75. UnitedHealth Group’s payout ratio is 35.75%.

UnitedHealth Group declared that its Board of Directors has initiated a stock buyback plan on Wednesday, June 6th that authorizes the company to repurchase 100,000,000 shares. This repurchase authorization authorizes the healthcare conglomerate to buy shares of its stock through open market purchases. Shares repurchase plans are often an indication that the company’s leadership believes its stock is undervalued.

In other news, Director Richard T. Burke sold 15,000 shares of the business’s stock in a transaction dated Monday, April 23rd. The stock was sold at an average price of $234.20, for a total value of $3,513,000.00. Following the completion of the transaction, the director now owns 1,761,533 shares of the company’s stock, valued at approximately $412,551,028.60. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Kenneth Irwin Shine sold 202 shares of the business’s stock in a transaction dated Thursday, April 19th. The shares were sold at an average price of $237.42, for a total value of $47,958.84. Following the completion of the transaction, the director now directly owns 28,948 shares of the company’s stock, valued at approximately $6,872,834.16. The disclosure for this sale can be found here. In the last three months, insiders sold 49,854 shares of company stock valued at $12,295,675. Insiders own 0.87% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply